Skip to main content
Top
Published in: Journal of Cardiothoracic Surgery 1/2021

Open Access 01-12-2021 | Heart Surgery | Research article

Intraoperative collection of autologous platelet-rich plasma from the cardiopulmonary bypass circuit upon initiation of extracorporeal circulation

Authors: Takeshi Honda, Yuji Kanaoka, Hiroshi Furukawa, Taishi Tamura, Noriaki Kuwada, Takahiko Yamasawa, Yoshiko Watanabe, Yasuhiro Yunoki, Atsushi Tabuchi, Kazuo Tanemoto

Published in: Journal of Cardiothoracic Surgery | Issue 1/2021

Login to get access

Abstract

Objectives

The aim of this study is to evaluate the possibility of the autologous platelet-rich plasma (PRP) collection from the cardiopulmonary bypass (CPB) circuit and to evaluate its effect on the aggregative function.

Methods

For seventy-two patients undergoing cardiac surgery with CPB, an autologous PRP was prepared using the Haemonetics Component Collection System® by drawing blood from the CPB circuit immediately after CPB was established. The blood samples were taken at three points for examination, A: beginning of surgery, B: immediately after heparin reversal with protamine following discontinuation of CPB, C: after the collected autologous PRP was returned to the patient. Platelet count and platelet aggregation ability were analyzed.

Results

The mean platelet count in autologous PRP was 5.5 (range: 3–14) units. Platelet count decreased by 115.0 (±27.3) × 1000/μl from A to B and increased by 27.3 ± 17.2 (× 1000/μl) from B to C.
When platelet aggregation was measured by Adenosine Diphosphate (ADP) 3.0 μM, it decreased by 42.6% ± 12.1% from A to B and increased by 8.7% ± 7.4% from B to C.

Conclusions

Autologous PRP can be safely collected by drawing blood from the CPB circuit, platelet count and aggregation ability significantly decreased after CPB including autologous PRP collection. Some improvement was detected in the number of the platelets count and platelet aggregation ability by administrating an autologous PRP even if autologous PRP is collected from CPB circuit.

Trial registration

UMI-CTR, UMIN000023776. Registered 1 October 2016.
Literature
1.
go back to reference Stover EP, Siegel LC, Hood PA, O’Riordan GE. Platelet-rich plasmapheresis with therapeutic platelet yield reduces allogenic red cell and platelet transfusions in high risk cardiac surgery. Anesthesiology. 1996;85:A68. Stover EP, Siegel LC, Hood PA, O’Riordan GE. Platelet-rich plasmapheresis with therapeutic platelet yield reduces allogenic red cell and platelet transfusions in high risk cardiac surgery. Anesthesiology. 1996;85:A68.
2.
go back to reference Kleinman S, Chan P, Robillard P. Risks associated with transfusion of cellular blood components in Canada. Transfus Med Rev. 2003;17:120–62.CrossRef Kleinman S, Chan P, Robillard P. Risks associated with transfusion of cellular blood components in Canada. Transfus Med Rev. 2003;17:120–62.CrossRef
3.
go back to reference Zhou SF, Estrera AL, Loubser P, Ignacio C, Panthayi S, Miller III, et al. Autologous platelet-rich plasma reduces transfusions during ascending aortic arch repair: a prospective, randomized, controlled trial. Ann Thorac Surg. 2015;99:1282–90.CrossRef Zhou SF, Estrera AL, Loubser P, Ignacio C, Panthayi S, Miller III, et al. Autologous platelet-rich plasma reduces transfusions during ascending aortic arch repair: a prospective, randomized, controlled trial. Ann Thorac Surg. 2015;99:1282–90.CrossRef
4.
go back to reference Takiuchi H, Tanemoto K. Impact of systemic heparinization on platelet function in autologous platelet-rich plasma. Kawasaki Med J. 2015;41:143–51. Takiuchi H, Tanemoto K. Impact of systemic heparinization on platelet function in autologous platelet-rich plasma. Kawasaki Med J. 2015;41:143–51.
5.
go back to reference Verrier ED, Boyle EM Jr. Endothelial cell injury in cardiovascular surgery. Ann Thorac Surg. 1996;62:915–22.CrossRef Verrier ED, Boyle EM Jr. Endothelial cell injury in cardiovascular surgery. Ann Thorac Surg. 1996;62:915–22.CrossRef
6.
go back to reference Sakatsume K, Saiki Y. Coagulation factors in artificial circulation. J Artif Organs. 2016;45:221–4. Sakatsume K, Saiki Y. Coagulation factors in artificial circulation. J Artif Organs. 2016;45:221–4.
7.
go back to reference Edmunds LH. Managing fibrinolysis without aprotinin. Ann Thorac Surg. 2010;89:324–31.CrossRef Edmunds LH. Managing fibrinolysis without aprotinin. Ann Thorac Surg. 2010;89:324–31.CrossRef
8.
go back to reference Zhai Q, Wang Y, Yuan Z, Zhang R, Tian A. Effects of platelet-rich plasmapheresis during cardiovascular surgery: A meta-analysis of randomized controlled clinical trials. J Clin Anesth. 2019;56:88–97.CrossRef Zhai Q, Wang Y, Yuan Z, Zhang R, Tian A. Effects of platelet-rich plasmapheresis during cardiovascular surgery: A meta-analysis of randomized controlled clinical trials. J Clin Anesth. 2019;56:88–97.CrossRef
9.
go back to reference Pabst D, Boone JB, Soleimani B, Brehm CE. Heparin-induced thrombocytopenia in patients on extracorporeal membrane oxygenation and the role of a heparin-bounded circuit. Perfusion. 2019;34:584–9.CrossRef Pabst D, Boone JB, Soleimani B, Brehm CE. Heparin-induced thrombocytopenia in patients on extracorporeal membrane oxygenation and the role of a heparin-bounded circuit. Perfusion. 2019;34:584–9.CrossRef
10.
go back to reference Amiral J, Bridey F, Dreyfus M, Vissac AM, Fressinaud E, Wolf M, et al. Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia. Thromb Haemost. 1992;68:95–6.CrossRef Amiral J, Bridey F, Dreyfus M, Vissac AM, Fressinaud E, Wolf M, et al. Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia. Thromb Haemost. 1992;68:95–6.CrossRef
11.
go back to reference Koster A, Sanger S, Knörig FJ, Kuppe H, Hetzer R, Loebe M. Autologous plasma and platelet sequestration at the beginning of cardiopulmonary bypass: a pilot investigation in five patients undergoing extended vascular surgery in deep hypothermia. ASAIO J. 2002;48:106–9.CrossRef Koster A, Sanger S, Knörig FJ, Kuppe H, Hetzer R, Loebe M. Autologous plasma and platelet sequestration at the beginning of cardiopulmonary bypass: a pilot investigation in five patients undergoing extended vascular surgery in deep hypothermia. ASAIO J. 2002;48:106–9.CrossRef
12.
go back to reference Takiuchi H, Tanemoto K. Optimal timing of clopidogrel discontinuation in Japanese patients: platelet aggregation test using the VerifyNow® system. Gen Thorac Cardiovasc Surg. 2015;63:601–6.CrossRef Takiuchi H, Tanemoto K. Optimal timing of clopidogrel discontinuation in Japanese patients: platelet aggregation test using the VerifyNow® system. Gen Thorac Cardiovasc Surg. 2015;63:601–6.CrossRef
Metadata
Title
Intraoperative collection of autologous platelet-rich plasma from the cardiopulmonary bypass circuit upon initiation of extracorporeal circulation
Authors
Takeshi Honda
Yuji Kanaoka
Hiroshi Furukawa
Taishi Tamura
Noriaki Kuwada
Takahiko Yamasawa
Yoshiko Watanabe
Yasuhiro Yunoki
Atsushi Tabuchi
Kazuo Tanemoto
Publication date
01-12-2021
Publisher
BioMed Central
Published in
Journal of Cardiothoracic Surgery / Issue 1/2021
Electronic ISSN: 1749-8090
DOI
https://doi.org/10.1186/s13019-020-01388-5

Other articles of this Issue 1/2021

Journal of Cardiothoracic Surgery 1/2021 Go to the issue